Auro Impex & Chemicals Limited (NSE:AUROIMPEX)
India · Delayed Price · Currency is INR 27.00
+1.00 (3.85%)
Jul 31, 2026, 3:23 PM IST
Auro Impex & Chemicals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 128.1 | 108.97 | 110.42 | 127.67 | 74.62 |
Cash & Short-Term Investments | 128.1 | 108.97 | 110.42 | 127.67 | 74.62 |
Cash Growth | 17.55% | -1.31% | -13.51% | 71.09% | 614.06% |
Accounts Receivable | 219.37 | 443.91 | 176.93 | 149.54 | 166.04 |
Other Receivables | - | 5.55 | 4.59 | 10.78 | 16.42 |
Receivables | 219.37 | 449.46 | 181.52 | 160.32 | 182.47 |
Inventory | 448.73 | 341.98 | 342.87 | 279.92 | 223.26 |
Prepaid Expenses | - | 1.9 | 1.48 | 9.56 | 0.54 |
Other Current Assets | 39.68 | 97.74 | 98.88 | 121.12 | 48.01 |
Total Current Assets | 835.88 | 1,000 | 735.17 | 698.59 | 528.9 |
Property, Plant & Equipment | 220.48 | 187.48 | 153.48 | 118.55 | 92.75 |
Long-Term Investments | 16.1 | 7.7 | - | - | - |
Other Long-Term Assets | 21.68 | 8.87 | 19.51 | 5.67 | 0.3 |
Total Assets | 1,094 | 1,204 | 908.16 | 822.81 | 621.96 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 105.97 | 51.65 | 58.11 | 32.7 | 56.98 |
Accrued Expenses | - | 9.06 | 7.69 | 4.87 | 2.83 |
Short-Term Debt | 370.81 | 527.21 | 237.53 | 370.98 | 285.77 |
Current Portion of Long-Term Debt | - | 23.73 | 18.62 | 19.15 | 15.3 |
Current Portion of Leases | - | 0.94 | 0.63 | 0.43 | 0.47 |
Current Income Taxes Payable | 3.19 | 3.84 | 9.31 | 15.69 | 4.99 |
Other Current Liabilities | 21.39 | 17.12 | 33.1 | 78.81 | 26.7 |
Total Current Liabilities | 501.35 | 633.56 | 364.99 | 522.62 | 393.04 |
Long-Term Debt | 55.22 | 76.41 | 93.05 | 96.05 | 96.93 |
Long-Term Leases | - | 1.77 | 1.57 | 1.41 | 0.97 |
Long-Term Deferred Tax Liabilities | 12.51 | 9.45 | 9.09 | 7.25 | 6.07 |
Other Long-Term Liabilities | 11.73 | 10.8 | 21.6 | 19.98 | 9.44 |
Total Liabilities | 580.81 | 731.99 | 490.31 | 647.31 | 506.45 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 122.01 | 122.01 | 122.01 | 92.81 | 7.73 |
Additional Paid-In Capital | - | 158.09 | 150.1 | - | 27.12 |
Retained Earnings | - | 150.25 | 103.97 | 40.92 | 38.88 |
Comprehensive Income & Other | 391.33 | 41.77 | 41.77 | 41.77 | 41.77 |
Shareholders' Equity | 513.34 | 472.11 | 417.85 | 175.5 | 115.5 |
Total Liabilities & Equity | 1,094 | 1,204 | 908.16 | 822.81 | 621.96 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 426.02 | 630.07 | 351.4 | 488.02 | 399.44 |
Net Cash (Debt) | -297.92 | -521.1 | -240.98 | -360.36 | -324.82 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -24.42 | -42.71 | -20.45 | -38.83 | -35.00 |
Filing Date Shares Outstanding | 12.2 | 12.2 | 12.2 | 9.28 | 9.28 |
Total Common Shares Outstanding | 12.2 | 12.2 | 12.2 | 9.28 | 9.28 |
Working Capital | 334.53 | 366.49 | 370.17 | 175.97 | 135.86 |
Book Value Per Share | 42.07 | 38.70 | 34.25 | 18.91 | 12.45 |
Tangible Book Value | 513.34 | 472.11 | 417.85 | 175.5 | 115.5 |
Tangible Book Value Per Share | 42.07 | 38.70 | 34.25 | 18.91 | 12.45 |
Buildings | - | 71.45 | 71.45 | 71.45 | 71.45 |
Machinery | - | 111.68 | 83.06 | 74.77 | 65.22 |
Construction In Progress | - | 64.49 | 55.28 | 27.52 | 6.4 |